Evidence map›Paper›PMID 23219605›Full record

ReviewMutation research

Evidence for base excision repair processing of DNA interstrand crosslinks.

Anbarasi Kothandapani, Steve M Patrick

Open access · greenAbstract readReview
In one paragraph

Review in Mutation research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanisms of DNA repair and mutagenesis induced by acetaldehyde, acrolein, aristolochic acids, and vinyl chloride.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2025
    Review
  4. Article
  5. Review
  6. Fanconi anemia-independent DNA inter-strand crosslink repair in eukaryotes.Progress in biophysics and molecular biology · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anbarasi KothandapaniDepartment of Biochemistry and Cancer Biology, University of Toledo - Health Science Campus, Toledo, OH 43614, USA. Electronic address: Anbarasi.Kothandapani@utoledo.edu.
Steve M PatrickDepartment of Biochemistry and Cancer Biology, University of Toledo - Health Science Campus, Toledo, OH 43614, USA. Electronic address: Stephan.Patrick@utoledo.edu.
Toledo Clinic Cancer Center · US

Funding

Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin SensitivityR01GM088249 · NIGMS · WAYNE STATE UNIVERSITY · PI PATRICK, STEVE M · 2010 to 2014
$1.4M
NIGMS NIH HHS 1R01-GM088249NIGMS NIH HHS R01 GM088249
6 · The paper itself

Abstract

Many bifunctional alkylating agents and anticancer drugs exert their cytotoxicity by producing cross links between the two complementary strands of DNA, termed interstrand crosslinks (ICLs). This blocks the strand separating processes during DNA replication and transcription, which can lead to cell cycle arrest and apoptosis. Cells use multiple DNA repair systems to eliminate the ICLs. Concerted action of repair proteins involved in Nucleotide Excision Repair and Homologous Recombination pathways are suggested to play a key role in the ICL repair. However, recent studies indicate a possible role for Base Excision Repair (BER) in mediating the cytotoxicity of ICL inducing agents in mammalian cells. Elucidating the mechanism of BER mediated modulation of ICL repair would help in understanding the recognition and removal of ICLs and aid in the development of potential therapeutic agents. In this review, the influence of BER proteins on ICL DNA repair and the possible mechanisms of action are discussed.

Indexed as

DNA RepairAnimalsCross-Linking ReagentsDNA DamageDNA ReplicationHumansRecombination, GeneticCross-Linking Reagents

Identifiers

PMID23219605
PMCPMC3637959
OpenAlexW2005421559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.